James T. Borello RIA’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$467K Sell
3,273
-287
-8% -$43.5K 0.1% 72
2026
Q2
$558K Buy
3,560
+33
+0.9% +$4.95K 0.12% 64
2026
Q1
$539K Buy
3,527
+937
+36% +$144K 0.14% 61
2025
Q4
$357K Buy
2,590
+15
+0.6% +$1.96K 0.09% 72
2025
Q3
$330K Hold
2,575
– – 0.09% 71
2025
Q2
$312K Hold
2,575
– – 0.09% 70
2025
Q1
$287K Hold
2,575
– – 0.09% 68
2024
Q4
$251K Hold
2,575
– – 0.09% 68
2024
Q3
$296K Hold
2,575
– – 0.12% 62
2024
Q2
$274K Hold
2,575
– – 0.12% 59
2024
Q1
$249K Buy
+2,575
New +$264K 0.11% 61

Other funds holding NVS

James T. Borello RIA's NVS Position: Q3 2026 in Review

James T. Borello RIA reduced its Novartis (NVS) stake by 8.1% in Q3 2026, selling an estimated $43.5K and leaving 3,273 shares worth $467K. The position accounts for 0.1% of the portfolio, ranked #72.

James T. Borello RIA first reported a position in NVS in Q1 2024 and has held it in 11 quarters since. The position peaked at $558K in Q2 2026. 447 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • James T. Borello RIA held 3,273 shares of Novartis worth $467K as of Q3 2026.
  • James T. Borello RIA sold 287 Novartis shares in Q3 2026, an estimated $43.5K.
  • Novartis made up 0.1% of James T. Borello RIA's portfolio in Q3 2026, its #72 holding.
  • James T. Borello RIA first reported a position in Novartis in Q1 2024 and has held it in 11 quarters since.
  • James T. Borello RIA's Novartis position peaked at $558K in Q2 2026.
  • 447 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on James T. Borello RIA's 13F filing for Q3 2026, filed 16 Oct 2026.